CVS Health Reports Fourth Quarter And Full-Year 2019 Results, Reflecting Strong Execution Across The Enterprise

Go back to CVS Health Reports Fourth Quarter And Full-Year 2019 Results, Reflecting Strong Execution Across The Enterprise

CVS Health (CVS) Tops Q4 EPS by 5c, Revenue Beats, Offers FY20 Guidance

February 12, 2020 6:46 AM EST

CVS Health (NYSE: CVS) reported Q4 EPS of $1.73, $0.05 better than the analyst estimate of $1.68. Revenue for the quarter came in at $66.9 billion versus the consensus estimate of $63.97 billion.

GUIDANCE:

CVS Health sees FY2020 EPS of $7.04-$7.17, versus the consensus of... More